| ID | Sequence | Length | GC content |
|---|---|---|---|
| CCGCAACCAGAGCCGCCGCCACGGUGAGUGGCUGGAUUCAGACCCCUGG… | 3125 nt | 0.6131 | |
| AACUUUCCUGCCCCUUCCCCGGCCAAGCCCAACUCCGGAUCUCGCUCUC… | 3103 nt | 0.6126 | |
| CUUCCUCUUCCGCUAACUUCCCGGCAGCGCGCCGCUCAGGGUGGGGGCC… | 3416 nt | 0.6241 | |
| AACUUUCCUGCCCCUUCCCCGGCCAAGCCCAACUCCGGAUCUCGCUCUC… | 3015 nt | 0.6116 | |
| CUUCCUCUUCCGCUAACUUCCCGGCAGCGCGCCGCUCAGGGUGGGGGCC… | 3293 nt | 0.6219 | |
| AACUUUCCUGCCCCUUCCCCGGCCAAGCCCAACUCCGGAUCUCGCUCUC… | 3012 nt | 0.6116 |
This gene encodes a subunit of the transcription factor complex nuclear factor-kappa-B (NFkB). The NFkB complex is expressed in numerous cell types and functions as a central activator of genes involved in inflammation and immune function. The protein encoded by this gene can function as both a transcriptional activator or repressor depending on its dimerization partner. The p100 full-length protein is co-translationally processed into a p52 active form. Chromosomal rearrangements and translocations of this locus have been observed in B cell lymphomas, some of which may result in the formation of fusion proteins. There is a pseudogene for this gene on chromosome 18. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
A study in rats demonstrated that the NFKB2 was identified as a potential regulator of methamphetamine reward and addiction, showing an up-down regulated expression pattern in whisker follicles following self-administration and withdrawal [Song et al. DOI:10.1038/s41598-018-29772-1]. In human sepsis patients, the NFKB2 was differentially expressed as part of non-canonical NF-kB signalling mediated by Dectin-1 in the heart and colon [Pinheiro da Silva et al. DOI:10.1111/jcmm.17938].